We are experienced therapeutic professionals delivering expertise, effective leadership, and strategic operational services to immunology clinical studies.
Our experience in immunology spans early-phase development through successful regulatory submission. This solid experience affords us with a thorough understanding of the treatment communities and patient populations with many key immunology disorders.
We have conducted 100+ immunology studies in recent years in wide-ranging indications. Our successful record of managing immunology clinical development programs has resulted in the approval of five important drugs for which we provided critical services.
Value-added solutions in immunology
Our immunology therapeutic experts review each study proposal and develop recommendations to help our clients achieve their goals, and we have a number of tools to guide our programs:
Novel database analytics to facilitate strategic country and site selection
Country-focused approach to start-up activities and in-depth knowledge of regulatory considerations
Strong relationships with immunology sites, renowned experts, and leading investigators worldwide
An enrollment validation process that yields accurate assessments of site enrollment rates and facilitates patient identification
recruitment and retention
A dedicated patient access group that facilitates recruitment and retention services
Core areas of immunology expertise
In recent years, our clinical development experience has spanned 15 indications, including these core areas:
# Clinical Studies87
Target # Clinical Sites5,200+
Target # Clinical Patients27,200+
Site Commercial Solutions
Our Site Commercial Solutions are comprehensive, end-to-end commercial management solutions built directly into your trial.
PRA Successfully Rescues Phase II Hematology Study
A phase II single-blind, randomized, placebo-controlled trial to study the efficacy and safety of Study Drug administered as adjunctive treatment to…
The Challenges of Patient Recruitment in Oncology Trials - Part 1
As the oncology environment continues to grow towards more targeted therapies, it is imperative that patient recruitment strategies focus on how to…